Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

The Graft Bone Substitute

K-Number: K191737 · 2020-02-14

Decision Date2020-02-14
Product CodeNPM
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

The Graft Bone Substitute is a medical device manufactured by Purgo Biologics, Inc.. It received FDA 510(k) clearance on 2020-02-14 under approval number K191737. The device is classified under product code NPM. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the The Graft Bone Substitute?

The Graft Bone Substitute is a medical device that received FDA 510(k) clearance on 2020-02-14. It is manufactured by Purgo Biologics, Inc.. The 510(k) number is K191737.

When was The Graft Bone Substitute approved by the FDA?

The Graft Bone Substitute received FDA 510(k) clearance on 2020-02-14, under approval number K191737.

What company makes The Graft Bone Substitute?

The Graft Bone Substitute is manufactured by Purgo Biologics, Inc..

What is the FDA product code for The Graft Bone Substitute?

The FDA product code for The Graft Bone Substitute is NPM.

Related Clinical Trials

Other Devices by Purgo Biologics, Inc.

Related Devices (Code: NPM)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.